.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

COVID-19
Sickle Cell Disease

ClinicalSee All >

ADHD
Allergy
Arterial Disease
Cardiology
Dermatology
Diabetes
Gastroenterology
Geriatric Medicine
Infectious Disease
Inflammation
Neurology
Psychiatry
Pulmonology
Rheumatology

Video Series

Insights
News Network
Peers & Perspectives
Post Conference Perspectives

About Us
Advertise
Editorial
Contact Us
Do Not Sell My Information
Privacy
Terms & Conditions

Case-Based Evidence for Cardiovascular Risk Reduction

EP. 1: Overview of Cardiovascular Risks

July 31st 2020

EP. 2: Prevalence of CVD Associated With Hypercholesterolemia

July 31st 2020

EP. 3: CVD Risk Reduction and Prevention

July 31st 2020

EP. 4: CVD: REDUCE-IT Trial

July 31st 2020

EP. 5: CVD: EVAPORATE Trial and COVID-19 Pilot Study

July 31st 2020

EP. 6: Add-On Therapy With Statins and PCSK9 Inhibitors in CVD

July 31st 2020

EP. 7: Adverse Effects of PCSK9 Inhibitors in CVD

July 31st 2020

EP. 8: CVD Real-World Case Scenario 1

July 31st 2020

EP. 9: CVD Real-World Case Scenario 2

July 31st 2020

EP. 10: CVD Real-World Case Scenario 3

July 31st 2020

Latest News

Nurse Involvement Crucial to Therapeutic Patient Education in Patients with AD

Improving Screening Strategies for Cardiac Sarcoidosis

Nora D. Volkow, MD: Combating COVID-Era Issues in Substance Use Disorder

View More News